IMR — Imricor Medical Systems Share Price
0.000.00%
Last trade - 00:00- AU$397.16m
- AU$404.01m
- $0.96m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 263.94 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -84.58% | ||
| Return on Equity | n/a | ||
| Operating Margin | -1698.61% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.7 | 0.7 | 0.82 | 0.62 | 0.96 | 4.09 | 17.86 | 8.44% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging (MRI)-compatible medical devices which can be used to carry out real-time interventional cardiac magnetic resonance imaging (iCMR) cardiac ablation procedures. The Company develops MRI-compatible products for cardiac catheter ablation procedures. The Vision-MR Ablation Catheter is the Company’s prime product offering, specifically designed to work under real-time MRI guidance. Its other products include Advantage-MR EP Recorder/Stimulator System, the Vision-MR Diagnostic Catheter and Vision-MR Dispersive Electrode. Advantage-MR EP Recorder/Stimulator System provides technology that allows the physician to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. It sells its capital and consumable products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 22nd, 2006
- Public Since
- August 30th, 2019
- No. of Shareholders
- 2,068
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 270,175,766
- Address
- 400 GATEWAY BLVD, BURNSVILLE, 55337-2559
- Web
- https://imricor.com
- Phone
- +1 9528188402
- Auditors
- BDO USA, LLP
Upcoming Events for IMR
Imricor Medical Systems Inc Annual Shareholders Meeting
Half Year 2025 Imricor Medical Systems Inc Earnings Release
Similar to IMR
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
FAQ
What is the Imricor Medical Systems share price?
As of Today at 21:15 UTC, shares in Imricor Medical Systems are trading at AU$1.47. This share price information is delayed by 15 minutes.
How has the Imricor Medical Systems share price performed this year?
Shares in Imricor Medical Systems last closed at AU$1.47 and the price had moved by +167.27% over the past 365 days. In terms of relative price strength the Imricor Medical Systems share price has outperformed the ASX All Ordinaries Index by +163.28% over the past year.
What are the analyst and broker recommendations for Imricor Medical Systems?
The overall consensus recommendation for Imricor Medical Systems is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Imricor Medical Systems dividend yield?
Imricor Medical Systems does not currently pay a dividend.
Does Imricor Medical Systems pay a dividend?
Imricor Medical Systems does not currently pay a dividend.
When does Imricor Medical Systems next pay dividends?
Imricor Medical Systems does not currently pay a dividend.
How do I buy Imricor Medical Systems shares?
To buy shares in Imricor Medical Systems you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Imricor Medical Systems?
As of the previous close price of AU$1.47, shares in Imricor Medical Systems had a market capitalisation of AU$397.16m.
Where are Imricor Medical Systems shares listed?
Here are the trading details for Imricor Medical Systems:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: IMR
What kind of share is Imricor Medical Systems?
Based on an overall assessment of its quality, value and momentum Imricor Medical Systems is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Imricor Medical Systems share price forecast for 2025?
The analyst consensus target price for shares in Imricor Medical Systems is AU$2.27. That is 54.36% above the last closing price of AU$1.47.
Analysts covering Imricor Medical Systems currently have a consensus Earnings Per Share (EPS) forecast of -$0.05 for the next financial year.
Find out moreWhat is the trend in the Imricor Medical Systems share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Imricor Medical Systems. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +99.14%.
As of the last closing price of AU$1.47, shares in Imricor Medical Systems were trading +54.33% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Imricor Medical Systems PE Ratio?
The Imricor Medical Systems PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$1.47.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Imricor Medical Systems?
We do not have data on Imricor Medical Systems' directors